{"id":27370,"date":"2022-07-19T12:37:37","date_gmt":"2022-07-19T19:37:37","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/uncategorized\/guillain-barre-syndrome-life-expectancy-2\/"},"modified":"2025-05-27T09:32:00","modified_gmt":"2025-05-27T16:32:00","slug":"guillain-barre-syndrome-life-expectancy","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/","title":{"rendered":"S\u00edndrome de Guillain-Barr\u00e9: esperanza de vida y perspectivas a largo plazo"},"content":{"rendered":"\n<p>Guillain-Barre syndrome (GBS) is a rare neurological condition that can have significant effects on those who are affected. Fortunately, individuals diagnosed with Guillain-Barre syndrome can have a positive long-term outlook and a good life expectancy when they receive prompt care and successful treatment for any accompanying infections.<\/p>\n\n\n\n<p>Statistics have shown that 70% of people with GBS eventually experience a full recovery with no negative impacts on their life expectancy. In this article, we will delve into the specifics of Guillain-Barre syndrome, including its survival rate, prognosis, treatment options, and more.<\/p>\n\n\n\n<div  id=\"call-to-action-2bb600740442415e09997ead28c3c680\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet IVIG Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tSpeak to a Specialist\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Understanding_Guillain-Barre_Syndrome\" >Understanding Guillain-Barre Syndrome<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Common_Triggers_of_GBS\" >Common Triggers of GBS<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#GBS_Treatment_Options\" >GBS Treatment Options<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Intravenous_Immunoglobulin_Therapy\" >Intravenous Immunoglobulin Therapy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Plasmapheresis\" >Plasmapheresis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Supportive_Care\" >Supportive Care<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Guillain-Barre_Syndrome_Prognosis_and_Recovery_Timeline\" >Guillain-Barre Syndrome Prognosis and Recovery Timeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Guillain-Barre_Syndrome_Survival_Rate\" >Guillain-Barre Syndrome Survival Rate<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Factors_Influencing_Guillain-Barre_Syndrome_Life_Expectancy\" >Factors Influencing Guillain-Barre Syndrome Life Expectancy<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Age_and_Comorbidities\" >Age and Comorbidities<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Severity_of_Initial_Symptoms\" >Severity of Initial Symptoms<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Long-term_Outlook_and_Quality_of_Life_for_GBS_Patients\" >Long-term Outlook and Quality of Life for GBS Patients<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Common_Long-term_Symptoms\" >Common Long-term Symptoms<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Ongoing_Management\" >Ongoing Management<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#Navigate_GBS_With_AmeriPharma%C2%AE_Specialty_Pharmacy\" >Navigate GBS With AmeriPharma\u00ae Specialty Pharmacy<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-understanding-guillain-barre-syndrome\"><span class=\"ez-toc-section\" id=\"Understanding_Guillain-Barre_Syndrome\"><\/span>Understanding Guillain-Barre Syndrome<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/guillain-barre-syndrome\/gbs-guillain-barre-syndrome\/\">Guillain-Barre Syndrome (GBS)<\/a> is an autoimmune disorder characterized by rapid onset muscle weakness and paralysis.<\/p>\n\n\n\n<p>In this condition, the body\u2019s immune system mistakenly attacks the peripheral nervous system. The demyelination of peripheral nerves occurs, which disrupts the transmission of signals between the nerves and muscles.<\/p>\n\n\n\n<p>This disruption can lead to muscle weakness and sensory disturbances. In severe cases, it can even cause respiratory failure, raising concerns for those with Guillain-Barre syndrome about their life expectancy.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-common-triggers-of-gbs\"><span class=\"ez-toc-section\" id=\"Common_Triggers_of_GBS\"><\/span>Common Triggers of GBS<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Several factors can trigger GBS, causing the immune system to attack the myelin sheath surrounding the nerves.<\/p>\n\n\n\n<p>The most common triggers for Guillain-Barre syndrome include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Infections:<\/strong> Respiratory or gastrointestinal infections, including those caused by campylobacter, Zika virus, and cytomegalovirus, can trigger GBS.<\/li>\n\n\n\n<li><strong>Vaccinations:<\/strong> In rare cases, some individuals may <a href=\"https:\/\/www.nature.com\/articles\/s41598-024-74729-2\" target=\"_blank\" rel=\"noreferrer noopener\">develop GBS following vaccinations<\/a>.<\/li>\n\n\n\n<li><strong>Surgery or Trauma:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11024248\/\" target=\"_blank\" rel=\"noreferrer noopener\">Physical trauma or surgical procedures<\/a> can sometimes precede the onset of GBS.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-gbs-treatment-options\"><span class=\"ez-toc-section\" id=\"GBS_Treatment_Options\"><\/span>GBS Treatment Options<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"540\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1.jpg\" alt=\"Close-up of an IV drip\" class=\"wp-image-27440\" style=\"width:1096px;height:auto\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1.jpg 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1-300x158.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1-768x405.jpg 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1-600x316.jpg 600w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1-86x45.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1-167x88.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1-280x148.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1-370x195.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-iv-drip-1-1024x540-1-960x506.jpg 960w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Effective management of Guillain-Barre syndrome is crucial for improving survival rates and outcomes. Various treatment options are available to increase the life expectancy of those with Guillain-Barre syndrome.<\/p>\n\n\n\n<p>Your healthcare team will determine the best course of therapy based on the severity of your condition. Here are some of the <a href=\"https:\/\/ameripharmaspecialty.com\/guillain-barre-syndrome\/guillain-barre-syndrome-treatment-options\/\">treatment options available for GBS<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-intravenous-immunoglobulin-therapy\"><span class=\"ez-toc-section\" id=\"Intravenous_Immunoglobulin_Therapy\"><\/span>Intravenous Immunoglobulin Therapy<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/guillain-barre-syndrome\/guillain-barre-syndrome-risk-factors\/\">Intravenous Immunoglobulin (IVIG) therapy<\/a> is one of the primary treatments for Guillain-Barre syndrome. This treatment involves administering a preparation of immunoglobulins derived from healthy blood donors.<\/p>\n\n\n\n<p>These antibodies modulate the immune response, reducing the harmful effects of the patient&#8217;s antibodies on the nervous system. <a href=\"https:\/\/www.pharmacytimes.com\/view\/study-intravenous-immunoglobulin-hastens-recovery-of-early-onset-guillain-barre\" target=\"_blank\" rel=\"noreferrer noopener\">Studies<\/a> suggest that early administration of IVIG can significantly improve the prognosis of Guillain-Barre syndrome, helping many individuals recover faster.<\/p>\n\n\n\n<p>Here is how IVIG is administered to improve the life expectancy of those with Guillain-Barre syndrome:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>A healthcare professional assesses the patient to determine the appropriate dosage.<\/li>\n\n\n\n<li>IVIG is prepared following proper handling and infusion protocols.<\/li>\n\n\n\n<li>The patient receives the IVIG infusion through an intravenous line, typically lasting 3 to 5 hours.<\/li>\n\n\n\n<li>Infusions may be repeated 14 to 28 days after the initial treatment.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-plasmapheresis\"><span class=\"ez-toc-section\" id=\"Plasmapheresis\"><\/span>Plasmapheresis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/guillain-barre-syndrome\/plasmapheresis-for-guillain-barre-syndrome-benefits-risks-and-dose\/\">Plasmapheresis<\/a>, or plasma exchange, is another effective treatment that improves the survival rate of those with Guillain-Barre syndrome. This procedure involves removing the patient\u2019s blood, separating the plasma from the blood cells, and discarding the plasma containing harmful antibodies.<\/p>\n\n\n\n<p>The remaining blood components are then returned to the patient\u2019s body. This treatment may improve life expectancy with Guillain-Barre syndrome by <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6464100\/\" target=\"_blank\" rel=\"noreferrer noopener\">speeding up recovery<\/a> and reducing the duration of severe symptoms.<\/p>\n\n\n\n<p>Here is how plasmapheresis is performed:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Blood is drawn from a large vein, typically in the arm.<\/li>\n\n\n\n<li>The blood is processed through a machine that separates the plasma from the blood cells.<\/li>\n\n\n\n<li>The unwanted plasma is removed, and the remaining blood cells are mixed with a replacement solution (like albumin).<\/li>\n\n\n\n<li>The treated blood is reinfused back into the patient&#8217;s bloodstream.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-supportive-care\"><span class=\"ez-toc-section\" id=\"Supportive_Care\"><\/span>Supportive Care<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Supportive care is crucial for patients and can significantly affect GBS life expectancy. This approach includes various therapies for alleviating symptoms and improving quality of life. It may involve pain management, physical and occupational therapy, and psychological support.<\/p>\n\n\n\n<p>Here is how supportive care is implemented to enhance the life expectancy of those with Guillain-Barre syndrome:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Physical therapy is initiated to maintain muscle strength and flexibility.<\/li>\n\n\n\n<li>Pain management strategies are developed, including medications to relieve discomfort.<\/li>\n\n\n\n<li>Occupational therapy focuses on helping individuals regain independence in daily activities.<\/li>\n\n\n\n<li>Psychological counseling is provided to address mental health issues and emotional challenges.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-guillain-barre-syndrome-prognosis-and-recovery-timeline\"><span class=\"ez-toc-section\" id=\"Guillain-Barre_Syndrome_Prognosis_and_Recovery_Timeline\"><\/span>Guillain-Barre Syndrome Prognosis and Recovery Timeline<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The point of greatest weakness typically occurs within four weeks after the initial symptoms appear. <a href=\"https:\/\/ameripharmaspecialty.com\/guillain-barre-syndrome\/guillain-barre-syndrome-symptoms\/\">Symptoms of Guillain-Barre syndrome<\/a> tend to stabilize during this period for days, weeks, or sometimes months.<\/p>\n\n\n\n<p>Recovery periods may vary between patients, and symptoms can resolve in as little as a few weeks up to a few years. However, some individuals still report ongoing improvement after 2 years.<\/p>\n\n\n\n<p>Long-term outcomes vary, but Guillain-Barre syndrome\u2019s life expectancy remains positive for many. Early intervention and appropriate treatment are crucial in enhancing recovery and overall quality of life.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-guillain-barre-syndrome-survival-rate\"><span class=\"ez-toc-section\" id=\"Guillain-Barre_Syndrome_Survival_Rate\"><\/span>Guillain-Barre Syndrome Survival Rate<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The survival rate for those diagnosed with GBS is notably high.<\/p>\n\n\n\n<p>An estimated <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/guillain-barre-syndrome\/diagnosis-treatment\/drc-20363006\" target=\"_blank\" rel=\"noreferrer noopener\">5% to 10%<\/a> of people experience delayed or partial recoveries. Meanwhile, the mortality rate for this disease is <a href=\"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3182904fcc\" target=\"_blank\" rel=\"noreferrer noopener\">3% according to a study<\/a>. The leading causes of death in this group were reported to be respiratory failure, pneumonia, cardiac arrest, and autonomic dysfunction.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-factors-influencing-guillain-barre-syndrome-life-expectancy\"><span class=\"ez-toc-section\" id=\"Factors_Influencing_Guillain-Barre_Syndrome_Life_Expectancy\"><\/span>Factors Influencing Guillain-Barre Syndrome Life Expectancy<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"693\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1.jpg\" alt=\"A carer walking with an elderly person in a park\" class=\"wp-image-27441\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1.jpg 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1-300x203.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1-768x520.jpg 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1-600x406.jpg 600w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1-86x58.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1-167x113.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1-280x189.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1-370x250.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/07\/guillain-barre-syndrome-life-expectancy-elderly-care-1-1024x693-1-960x650.jpg 960w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Various factors can affect the survival rate and life expectancy of those with GBS. Here is a closer look at some of them.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-age-and-comorbidities\"><span class=\"ez-toc-section\" id=\"Age_and_Comorbidities\"><\/span>Age and Comorbidities<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Older individuals typically face a more challenging recovery due to a decreased physiological resilience, which may slow healing and increase the severity of symptoms.<\/p>\n\n\n\n<p>Additionally, pre-existing health conditions, such as diabetes or cardiovascular disease, can further complicate recovery and adversely affect the overall Guillain-Barre syndrome prognosis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-severity-of-initial-symptoms\"><span class=\"ez-toc-section\" id=\"Severity_of_Initial_Symptoms\"><\/span>Severity of Initial Symptoms<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The severity of initial symptoms in Guillain-Barre syndrome directly affects life expectancy and the likelihood of full recovery. Those who present with more profound muscle weakness and rapid progression of signs face a more challenging prognosis.<\/p>\n\n\n\n<p>Severe initial symptoms can lead to complications like respiratory failure or autonomic dysfunction, which may increase mortality risk. Conversely, those with milder symptoms of Guillain-Barre syndrome tend to have a better survival rate and a higher chance of complete recovery.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-long-term-outlook-and-quality-of-life-for-gbs-patients\"><span class=\"ez-toc-section\" id=\"Long-term_Outlook_and_Quality_of_Life_for_GBS_Patients\"><\/span>Long-term Outlook and Quality of Life for GBS Patients<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The long-term outlook and life expectancy for Guillain-Barre syndrome varies for each individual. However, many experience significant improvements in their quality of life through ongoing management and support.<\/p>\n\n\n\n<p>Here is a closer look at the most common long-term symptoms and their management strategies.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-common-long-term-symptoms\"><span class=\"ez-toc-section\" id=\"Common_Long-term_Symptoms\"><\/span>Common Long-term Symptoms<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Recognizing common long-term symptoms is essential to manage Guillain-Barre syndrome effectively and improve its prognosis.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Approximately 3% may suffer a relapse of muscle weakness and tingling sensations many years after the initial attack.<\/li>\n\n\n\n<li>Approximately 15% of individuals may experience long-term weakness; some may require ongoing use of a walker, wheelchair, or ankle support. Muscle strength may not return uniformly.<\/li>\n\n\n\n<li>Approximately 30% experience residual weakness after 3 years.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ongoing-management\"><span class=\"ez-toc-section\" id=\"Ongoing_Management\"><\/span>Ongoing Management<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Fatigue, pain, and other ongoing sensations can sometimes be troublesome. The best way to deal with fatigue is by engaging in pacing activities and taking time for adequate rest when fatigue sets in.<\/p>\n\n\n\n<p>Those with Guillain-Barre syndrome also face emotional difficulties as they contemplate their life expectancy. It is often very challenging for individuals to deal with sudden paralysis and the need to depend on others for help with routine activities.<\/p>\n\n\n\n<p>Individuals are encouraged to seek psychological support as it helps them adapt and may contribute to improving the overall GBS life expectancy. Support groups often ease emotional strain and provide valuable information. [<a href=\"https:\/\/www.ninds.nih.gov\/health-information\/disorders\/guillain-barre-syndrome\" target=\"_blank\" rel=\"noreferrer noopener\">2<\/a>]<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-navigate-gbs-with-ameripharma-specialty-pharmacy\"><span class=\"ez-toc-section\" id=\"Navigate_GBS_With_AmeriPharma%C2%AE_Specialty_Pharmacy\"><\/span>Navigate GBS With AmeriPharma\u00ae Specialty Pharmacy<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Guillain-Barre syndrome\u2019s high survival rate means you can effectively manage this condition with timely treatment. <a href=\"https:\/\/ameripharmaspecialty.com\/about-us\/\">AmeriPharma\u00ae Specialty Pharmacy<\/a> is here to provide the treatment you need.<\/p>\n\n\n\n<p>Our URAC-accredited <a href=\"https:\/\/ameripharmaspecialty.com\/\">specialty pharmacy<\/a> offers <a href=\"https:\/\/ameripharmaspecialty.com\/ig-home-infusion\/\">at-home IVIG infusions<\/a> and hard-to-find medications in over 40 US states and territories.<\/p>\n\n\n\n<p>Contact us today if you\u2019re dealing with Guillain-Barre syndrome and improve your life expectancy with our full-service coordination, <a href=\"https:\/\/ameripharmaspecialty.com\/financial-assistance\/\">copay assistance<\/a>, and 24\/7\/365 support.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Afortunadamente, quienes han sido diagnosticados con SGB tienen actualmente una perspectiva de vida positiva a largo plazo gracias al inicio oportuno de cuidados intensivos y al tratamiento eficaz de la infecci\u00f3n. Las estad\u00edsticas demuestran que el 70% de las personas con SGB finalmente se recuperan por completo.\u00a0<\/p>","protected":false},"author":7,"featured_media":27369,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[20],"tags":[8],"class_list":["post-27370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-guillain-barre-syndrome","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Guillain-Barre Syndrome Life Expectancy and Long-term Outlook - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guillain-Barre Syndrome Life Expectancy and Long-term Outlook - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Fortunately, those diagnosed with GBS currently have a positive long-term outlook and life expectancy with the initiation of prompt intensive care, and successful treatment of infection. Statistics have shown that 70% of people with GBS eventually experience full recovery.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-19T19:37:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T16:32:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"Guillain-Barre Syndrome Life Expectancy and Long-term Outlook\",\"datePublished\":\"2022-07-19T19:37:37+00:00\",\"dateModified\":\"2025-05-27T16:32:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/\"},\"wordCount\":1274,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/gbs-life-expectancy-walker.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"Guillain-Barre Syndrome\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/\",\"name\":\"Guillain-Barre Syndrome Life Expectancy and Long-term Outlook - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/gbs-life-expectancy-walker.jpg\",\"datePublished\":\"2022-07-19T19:37:37+00:00\",\"dateModified\":\"2025-05-27T16:32:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/gbs-life-expectancy-walker.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/gbs-life-expectancy-walker.jpg\",\"width\":1280,\"height\":853,\"caption\":\"A nurse smiling at a GBS patient with a walker\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/guillain-barre-syndrome\\\/guillain-barre-syndrome-life-expectancy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guillain-Barre Syndrome Life Expectancy and Long-term Outlook\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"S\u00edndrome de Guillain-Barr\u00e9: Expectativa de vida y pron\u00f3stico a largo plazo - AmeriPharma\u00ae Atenci\u00f3n especializada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/","og_locale":"es_MX","og_type":"article","og_title":"Guillain-Barre Syndrome Life Expectancy and Long-term Outlook - AmeriPharma\u00ae Specialty Care","og_description":"Fortunately, those diagnosed with GBS currently have a positive long-term outlook and life expectancy with the initiation of prompt intensive care, and successful treatment of infection. Statistics have shown that 70% of people with GBS eventually experience full recovery.\u00a0","og_url":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2022-07-19T19:37:37+00:00","article_modified_time":"2025-05-27T16:32:00+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"Guillain-Barre Syndrome Life Expectancy and Long-term Outlook","datePublished":"2022-07-19T19:37:37+00:00","dateModified":"2025-05-27T16:32:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/"},"wordCount":1274,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["Guillain-Barre Syndrome"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/","url":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/","name":"S\u00edndrome de Guillain-Barr\u00e9: Expectativa de vida y pron\u00f3stico a largo plazo - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg","datePublished":"2022-07-19T19:37:37+00:00","dateModified":"2025-05-27T16:32:00+00:00","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg","width":1280,"height":853,"caption":"A nurse smiling at a GBS patient with a walker"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-life-expectancy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"Guillain-Barre Syndrome Life Expectancy and Long-term Outlook"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Fortunately, those diagnosed with GBS currently have a positive long-term outlook and life expectancy with the initiation of prompt intensive care, and successful treatment of infection. Statistics have shown that 70% of people with GBS eventually experience full recovery.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/gbs-life-expectancy-walker.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/guillain-barre-syndrome\/\" rel=\"category tag\">Guillain-Barre Syndrome<\/a>","rttpg_excerpt":"Fortunately, those diagnosed with GBS currently have a positive long-term outlook and life expectancy with the initiation of prompt intensive care, and successful treatment of infection. Statistics have shown that 70% of people with GBS eventually experience full recovery.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27370"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27370\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27369"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27370"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}